MRO
50
4
REGN
38
-2
AMGN
42
-4
NAVI
52
-2
CSX
57
-4
TRIP
50
-4
MAR
63
-5
CMG
66
-4
DGX
48
11
ISRG
71
-5
WDC
37
-3
FRT
41
-2
DTE
43
5
PEP
39
-9
HBI
58
3
TXN
43
-5
KR
36
-6
PFE
14
-7
STT
64
2
MSFT
48
-9
MRO
50
4
REGN
38
-2
AMGN
42
-4
NAVI
52
-2
CSX
57
-4
TRIP
50
-4
MAR
63
-5
CMG
66
-4
DGX
48
11
ISRG
71
-5
WDC
37
-3
FRT
41
-2
DTE
43
5
PEP
39
-9
HBI
58
3
TXN
43
-5
KR
36
-6
PFE
14
-7
STT
64
2
MSFT
48
-9
Financhill
Back

Morgan Stanley Emerging Markets Domestic Debt Fund Vs. Avidity Biosciences Industry Stock Comparison

Sell
41

EDD
Morgan Stanley Emerging Markets Domestic Debt Fund

Last Price:
4.63
Seasonality Move:
1.54%
Sell
28

RNA
Avidity Biosciences

Last Price:
42.16
Seasonality Move:
39.98%
Sell
41
Morgan Stanley Emerging Markets Domestic Debt Fund (EDD) is a Sell

Is Morgan Stanley Emerging Markets Domestic Debt Fund a Buy, Sell or Hold?

  • The current Morgan Stanley Emerging Markets Domestic Debt Fund [EDD] share price is $4.64. The Score for EDD is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • EDD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Avidity Biosciences (RNA) is a Sell

Is Avidity Biosciences a Buy, Sell or Hold?

  • The current Avidity Biosciences [RNA] share price is $42.18. The Score for RNA is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • RNA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EDD Stock Price Chart

What is Morgan Stanley Emerging Markets Domestic Debt Fund's stock price today?

  • The Morgan Stanley Emerging Markets Domestic Debt Fund share price today is $4.64
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDD is experiencing buying pressure, which is a positive indicator for future bullish movement.

RNA Stock Price Chart

What is Avidity Biosciences's stock price today?

  • The Avidity Biosciences share price today is $42.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNA is experiencing selling pressure, which indicates risk of future bearish movement.

EDD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 37.52 Sell
Chaikin Money Flow: 166862 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.67 - 4.85) Sell
Bollinger Bands (100): (4.73 - 5.01) Sell

RNA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.53 Buy
Relative Strength Index (14 RSI): 42.17 Sell
Chaikin Money Flow: -1839481 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.78 - 48.76) Sell
Bollinger Bands (100): (41.56 - 46.96) Sell

EDD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.71 Sell
20-day SMA: 4.73 Sell
50-day SMA: 4.89 Sell
200-day SMA: 4.78 Sell
8-day EMA: 4.68 Sell
20-day EMA: 4.74 Sell
50-day EMA: 4.82 Sell
200-day EMA: 4.79 Sell

RNA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.51 Sell
20-day SMA: 45.87 Sell
50-day SMA: 45.1 Sell
200-day SMA: 34.2 Buy
8-day EMA: 46.84 Sell
20-day EMA: 46.32 Sell
50-day EMA: 45.24 Sell
200-day EMA: 35.58 Buy

Morgan Stanley Emerging Markets Domestic Debt Fund Earnings Growth & EDD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Avidity Biosciences Earnings Growth & RNA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and a decrease next year of $0.25 per share.

Morgan Stanley Emerging Markets Domestic Debt Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Avidity Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):